Avalyn Pharma Inc
Price
FilingsNewest: 8-K, Director or officer changeSep 16 →Insiders4 insiders bought $25.0M in 4 open-market buys. No sales.→HoldersFMR 13.2%Novo Holdings A/S 8.8%SR One 7.5%→Financing →
From the filings
Figures
- Cash and equivalents
- $264.2Mat the last balance sheet
- Total debt
- $14.8Mat the last balance sheet
- Shares outstanding
- 44.3M shareson issue